# Lexicon Pharmaceuticals, Inc.: Form 8-K, filed Jul 8, 2024

- Company: [Lexicon Pharmaceuticals, Inc.](/companies/lxrx.md) (CIK 1062822)
- Form: 8-K
- Filed: 2024-07-08
- Accepted by EDGAR: Jul 8, 2024, 09:15 ET
- Period: 2024-07-03
- Accession: 0001062822-24-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000036/lxrx-20240703.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000036/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1062822/000106282224000036/lxrx-20240703.htm

Filed Jul 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001062822-24-000036. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.
